1. Home
  2. IH vs ONCY Comparison

IH vs ONCY Comparison

Compare IH & ONCY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo iHuman Inc.

IH

iHuman Inc.

HOLD

Current Price

$2.19

Market Cap

116.0M

Sector

Real Estate

ML Signal

HOLD

Logo Oncolytics Biotech Inc.

ONCY

Oncolytics Biotech Inc.

HOLD

Current Price

$0.95

Market Cap

106.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
IH
ONCY
Founded
1996
1998
Country
China
Canada
Employees
N/A
N/A
Industry
Other Consumer Services
Pharmaceuticals and Biotechnology
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
116.0M
106.1M
IPO Year
2020
1999

Fundamental Metrics

Financial Performance
Metric
IH
ONCY
Price
$2.19
$0.95
Analyst Decision
Strong Buy
Analyst Count
0
6
Target Price
N/A
$6.00
AVG Volume (30 Days)
9.3K
645.1K
Earning Date
12-19-2025
11-12-2025
Dividend Yield
3.88%
N/A
EPS Growth
N/A
N/A
EPS
0.29
N/A
Revenue
$123,215,612.00
N/A
Revenue This Year
$39.02
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$7.65
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.55
$0.33
52 Week High
$3.60
$1.51

Technical Indicators

Market Signals
Indicator
IH
ONCY
Relative Strength Index (RSI) 38.84 45.03
Support Level $2.15 $0.94
Resistance Level $2.40 $1.00
Average True Range (ATR) 0.12 0.06
MACD 0.00 0.00
Stochastic Oscillator 21.44 26.16

Price Performance

Historical Comparison
IH
ONCY

About IH iHuman Inc.

iHuman Inc is a Chinese company that uses artificial intelligence to create technology-driven puzzle products for children, making parenting easier and children happier. The company offers a range of intellectual development products that are designed to make the child-rearing experience more manageable for parents while turning intellectual development into a fun journey for children. Its revenue is generated from subscription fees paid by users for premium content on their self-directed and interactive online applications, as well as offline products and other sources.

About ONCY Oncolytics Biotech Inc.

Oncolytics Biotech Inc is a clinical-stage biopharmaceutical company. The company is focused on the discovery and development of pharmaceutical products for the treatment of cancers that have not been treated with therapeutics. It is developing pelareorep, an immunotherapeutic agent that improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The other projects in the company's pipeline include Bracelet-1 for the treatment of Breast Cancer, Goblet cohort-1, and Goblet cohort-5 for the treatment of Gastro-Intestinal Cancer among others.

Share on Social Networks: